News for Regeneron Pharmaceuticals Inc - Google Finance

Regeneron Pharmaceuticals Inc. (REGN) Has Risen To A New High On Q1 ...

Fri, 03 May 2013 20:14:51 GMT

Regeneron Pharmaceuticals Inc. (REGN) Has Risen To A New High On Q1 ...
NASDAQ - May 3, 2013

(RTTNews.com) - Regeneron Pharmaceuticals Inc. ( REGN ) reported first quarter net income of $0.90 per share Friday morning, up from $0.11 per share in the prior year.

Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY), Onyx Pharmaceuticals, Inc. (ONXX ...

Sun, 19 May 2013 16:39:16 GMT

Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY), Onyx Pharmaceuticals, Inc. (ONXX ...
Insider Monkey (blog) - May 19, 2013

What to watch at ASCO Regeneron Pharmaceuticals Inc (NASDAQ:REGN), perhaps best known for its highly successful wet age-related macular degeneration drug Eylea, released two promising abstracts for ASCO on monoclonal antibodies with potential ...

Regeneron Pharmaceuticals, Inc: Eylea Fundamentals Improving Amid Thinning ...

Thu, 09 May 2013 15:36:48 GMT

Regeneron Pharmaceuticals, Inc: Eylea Fundamentals Improving Amid Thinning ...
iStockAnalyst (press release) - May 9, 2013

(By Mani) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares are on the bullish territory on Eylea fundamentals, which continue to improve with long-term sustainability of ophthalmology related revenues.

Regeneron Pharms Rating Reiterated by TheStreet (REGN) - Mideast Time
Regeneron Pharms Receives Neutral Rating from Zacks (REGN) - Daily Political

REGENERON PHARMACEUTICALS INC : Sanofi and Regeneron Announce ...

Wed, 15 May 2013 05:04:18 GMT

REGENERON PHARMACEUTICALS INC : Sanofi and Regeneron Announce ...
4-traders (press release) - May 15, 2013

PARIS and TARRYTOWN, N.Y., May 15, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the COMPARE and ASCERTAIN trials of sarilumab, the first fully ...

Sanofi recruits patients for arthritis trials - Reuters UK

Regeneron Pharmaceuticals Inc (REGN): Key Data To Keep An Eye On

Fri, 26 Apr 2013 15:54:36 GMT

Regeneron Pharmaceuticals Inc (REGN): Key Data To Keep An Eye On
Insider Monkey (blog) - Apr 26, 2013

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) investors should be aware of an increase in enthusiasm from smart money in recent months.

My top stock pick - MarketWatch

NASDAQ Active Stock Watch List: Idenix Pharmaceuticals Inc. (NASDAQ:IDIX ...

Wed, 15 May 2013 12:27:10 GMT

NASDAQ Active Stock Watch List: Idenix Pharmaceuticals Inc. (NASDAQ:IDIX ...
SBWire (press release) - May 15, 2013

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally closed ...

REGENERON PHARMACEUTICALS INC : Regeneron Acquires Full Rights to ...

Fri, 03 May 2013 10:40:45 GMT

REGENERON PHARMACEUTICALS INC : Regeneron Acquires Full Rights to ...
4-traders (press release) - May 3, 2013

TARRYTOWN, N.Y., May 3, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at ...

Spectra Energy Corp . ( NYSE : SE ) and Regeneron Pharmaceuticals Inc ... - Property Mentor
(REGN:NASDAQ GS) - Businessweek

The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron ...

Thu, 16 May 2013 17:11:21 GMT

The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron ...
Sacramento Bee - May 16, 2013

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Genomic Health Inc. (Nasdaq:GHDX), Sanofi (NYSE:SNY), Regeneron Pharmaceuticals, ...

Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million Compensation

Mon, 29 Apr 2013 19:01:26 GMT

Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million Compensation
Fox Business - Apr 29, 2013

Dow Jones Newswires. Regeneron Pharmaceuticals Inc.'s (REGN) stock price tripled last year, and the compensation of co-founder and Chief Executive Leonard Schleifer nearly did, too.

NASDAQ Decliners Watch List: Regeneron Pharmaceuticals, Inc. (NASDAQ ...

Wed, 08 May 2013 12:38:58 GMT

NASDAQ Decliners Watch List: Regeneron Pharmaceuticals, Inc. (NASDAQ ...
SBWire (press release) - May 8, 2013

New York, NY -- (SBWIRE) -- 05/08/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and Biogen Idec Inc.